Search results
Author(s):
Mitchell T Saltzberg
Added:
3 years ago
Volume Overload in Heart Failure
The burden of heart failure (HF) remains formidable in the US, with nearly one million annual hospital admissions and frequent outpatient visits to a variety of care providers.1 While HF outcomes have improved modestly over the past several decades, many patients still struggle to maintain a satisfactory quality of life.2 Implantable cardioverter–defibrillators…
View more
Author(s):
Veraprapas Kittipibul
,
Marat Fudim
Added:
3 months ago
Author(s):
Stuart D Katz
Added:
3 years ago
A recent study reported the clinical characteristics and outcomes of 43 non-edematous ambulatory patients with congestive heart failure, in whom clinical volume status was categorized by a direct measurement of blood volume by a radioisotope technique.1 Despite on-going treatment with high doses of loop diuretics and few physical signs of congestion, 65% of the subjects in this cohort were found…
View more
Author(s):
Sanjiv Kaul
Added:
3 years ago
Contrast echocardiography (CE) is 40 years old this year. Gamiak and Shah first described the use of ultrasound (US) contrast in 1968 during the early days of M-mode echocardiography.1 In that study, US contrast was produced by inadvertently introducing air bubbles in the indocyanine green solution that was injected into the left heart during cardiac catheterisation and observing its appearance…
View more
Author(s):
Maria Rosa Costanzo
Added:
3 years ago
In the US, 90% of the one million annual hospitalizations for heart failure (HF) are due to volume overload.1,2 Hypervolemia contributes to HF progression and mortality. Guidelines recommend that therapy for HF patients be aimed at achieving euvolemia. Intravenous loop diuretics induce rapid diuresis that reduces lung congestion and dyspnea. However, the effectiveness of loop diuretics declines…
View more
Author(s):
Frédéric Michard
Added:
3 years ago
Volume expansion is one of the most common therapeutic procedures in intensive care units (ICUs). There is no doubt that in some cases (e.g. hemorrhage or severe diarrhea) care-givers can reasonably rely on clinical examination to identify patients who will benefit from fluid loading. However, in more complex—but not uncommon—situations (e.g. septic shock), both clinical examination and…
View more
Author(s):
Marat Fudim
Added:
1 year ago
Dr Marat Fudim (Duke University School of Medicine, NC, US) joins us on-site at Heart Failure 2022 to outline the findings of REBALANCE-HF Roll In Cohort (NCT04592445).
In this study, patients with heart failure with preserved ejection fraction (HFpEF) were randomized 1:1 to receive either ablation of the right greater splanchnic nerve (GSN) or sham at the time of the procedure. The study aimed…
View more
Author(s):
James N Kirkpatrick
,
Susan E Wiegers
,
J Eduardo Rame
,
et al
Added:
3 years ago
There are at least five million patients with heart failure (HF) in the US, 5% of whom are considered end-stage.1 Mechanical circulatory support (MCS) in the form of ventricular assist devices (VADs) is becoming an increasingly important option for these patients. Previously reserved for rescuing patients in the throes of refractory cardiogenic shock, MCS is now a mainstay of end-stage heart…
View more
Author(s):
W Kevin Tsai
,
Kathleen M Holohan
,
Kim Allan Williams
Added:
3 years ago
Coronary artery disease (CAD) represents a tremendous financial and health burden as the leading cause of death in the US.1 Acute coronary syndrome and its subsequent manifestations, including heart failure and need for cardiac transplantation, are associated with significant morbidity and mortality. Hypertension, dyslipidemia, tobacco abuse, diabetes, chronic kidney disease, and family history…
View more
Author(s):
Marc Sirol
Added:
3 years ago
Atherosclerosis and its thrombotic complications are the first cause of mortality and morbidity in industrialized countries. Furthermore, despite pharmacological intervention and lifestyle changes, cardiovascular disease (CVD) continues to be the principal cause of death in the US. Despite great advances in the understanding of the initiation and progression of atherosclerosis and its risk…
View more